USPTO Issues New Patent to Acurx for DNA Polymerase IIIC Inhibitor Technology
The newly granted patent covers DNA polymerase IIIC inhibitors, including compositions of matter, methods of use and pharmaceutical formulations, further strengthening Acurx’s Intellectual Property (IP) portfolio and expanding its growing patent estate in the US and international markets.
Patent | 03/02/2026 | By News Bureau
Innocan Pharma Secures its First Patent in India for its Liposomal CBD Injection
This granted patent protects Innocan's synthetic Cannabidiol-loaded Liposome Injection Platform (LPT-CBD), designed for precise dosing and sustained release of Synthetic CBD into the bloodstream.
Patent | 19/02/2025 | By Aishwarya | 394
BioLineRx Gets USPTO Allowance of New Composition of Matter Patent on Motixafortide
The patent strengthens BioLineRx's robust intellectual property (IP) estate and extends its patent protection on motixafortide in the US through December 2041.
Patent | 18/10/2024 | By Aishwarya | 383
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy